Literature DB >> 27635471

Trial Reporting in ClinicalTrials.gov - The Final Rule.

Deborah A Zarin1, Tony Tse1, Rebecca J Williams1, Sarah Carr1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27635471      PMCID： PMC5225905          DOI： 10.1056/NEJMsr1611785

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

1.  Clinical trial registration: a statement from the International Committee of Medical Journal Editors.

Authors:  Catherine De Angelis; Jeffrey M Drazen; Frank A Frizelle; Charlotte Haug; John Hoey; Richard Horton; Sheldon Kotzin; Christine Laine; Ana Marusic; A John P M Overbeke; Torben V Schroeder; Hal C Sox; Martin B Van Der Weyden
Journal:  N Engl J Med       Date:  2004-09-08       Impact factor: 91.245

2.  Issues in the registration of clinical trials.

Authors:  Deborah A Zarin; Nicholas C Ide; Tony Tse; William R Harlan; Joyce C West; Donald A B Lindberg
Journal:  JAMA       Date:  2007-05-16       Impact factor: 56.272

3.  The evolution of trial registries and their use to assess the clinical trial enterprise.

Authors:  Kay Dickersin; Drummond Rennie
Journal:  JAMA       Date:  2012-05-02       Impact factor: 56.272

4.  Trial-results reporting and academic medical centers.

Authors:  Deborah A Zarin; Tony Tse; Joseph S Ross
Journal:  N Engl J Med       Date:  2015-05-20       Impact factor: 91.245

5.  Clinical Trials Registration and Results Information Submission. Final rule.

Authors: 
Journal:  Fed Regist       Date:  2016-09-21

6.  Toward a New Era of Trust and Transparency in Clinical Trials.

Authors:  Kathy L Hudson; Michael S Lauer; Francis S Collins
Journal:  JAMA       Date:  2016-10-04       Impact factor: 56.272

7.  The ClinicalTrials.gov results database--update and key issues.

Authors:  Deborah A Zarin; Tony Tse; Rebecca J Williams; Robert M Califf; Nicholas C Ide
Journal:  N Engl J Med       Date:  2011-03-03       Impact factor: 91.245

8.  The proposed rule for U.S. clinical trial registration and results submission.

Authors:  Deborah A Zarin; Tony Tse; Jerry Sheehan
Journal:  N Engl J Med       Date:  2014-12-24       Impact factor: 91.245

9.  Compliance with results reporting at ClinicalTrials.gov.

Authors:  Monique L Anderson; Karen Chiswell; Eric D Peterson; Asba Tasneem; James Topping; Robert M Califf
Journal:  N Engl J Med       Date:  2015-03-12       Impact factor: 91.245

10.  Timing and completeness of trial results posted at ClinicalTrials.gov and published in journals.

Authors:  Carolina Riveros; Agnes Dechartres; Elodie Perrodeau; Romana Haneef; Isabelle Boutron; Philippe Ravaud
Journal:  PLoS Med       Date:  2013-12-03       Impact factor: 11.069
View more
  98 in total

1.  Adverse Events Associated with Nonsurgical Treatments for Urinary Incontinence in Women: a Systematic Review.

Authors:  Ethan M Balk; Gaelen P Adam; Katherine Corsi; Amanda Mogul; Thomas A Trikalinos; Peter C Jeppson
Journal:  J Gen Intern Med       Date:  2019-05-06       Impact factor: 5.128

2.  Rapid network meta-analysis using data from Food and Drug Administration approval packages is feasible but with limitations.

Authors:  Lin Wang; Benjamin Rouse; Arielle Marks-Anglin; Rui Duan; Qiyuan Shi; Kevin Quach; Yong Chen; Christopher Cameron; Christopher H Schmid; Tianjing Li
Journal:  J Clin Epidemiol       Date:  2019-06-18       Impact factor: 6.437

3.  Comparing and Contrasting A Priori and A Posteriori Generalizability Assessment of Clinical Trials on Type 2 Diabetes Mellitus.

Authors:  Zhe He; Arturo Gonzalez-Izquierdo; Spiros Denaxas; Andrei Sura; Yi Guo; William R Hogan; Elizabeth Shenkman; Jiang Bian
Journal:  AMIA Annu Symp Proc       Date:  2018-04-16

4.  Reaping the Bounty of Publicly Available Clinical Trial Consent Forms.

Authors:  Holly Fernandez Lynch; Emily A Largent; Deborah A Zarin
Journal:  IRB       Date:  2017 Nov-Dec

5.  Generic Modified-Release Antiepileptic Drugs: No Difference Within Formulations, but Important Differences Across Formulations.

Authors:  Cynthia L Harden
Journal:  Epilepsy Curr       Date:  2017 Jan-Feb       Impact factor: 7.500

Review 6.  Efficient design of clinical trials and epidemiological research: is it possible?

Authors:  Michael S Lauer; David Gordon; Gina Wei; Gail Pearson
Journal:  Nat Rev Cardiol       Date:  2017-04-27       Impact factor: 32.419

7.  Summarising the Evidence for Drug Safety: A Methodological Discussion of Different Meta-Analysis Approaches.

Authors:  Guillermo Prada-Ramallal; Bahi Takkouche; Adolfo Figueiras
Journal:  Drug Saf       Date:  2017-07       Impact factor: 5.606

8.  Toward a New Era of Trust and Transparency in Clinical Trials.

Authors:  Kathy L Hudson; Michael S Lauer; Francis S Collins
Journal:  JAMA       Date:  2016-10-04       Impact factor: 56.272

9.  Factors associated with reporting results for pulmonary clinical trials in ClinicalTrials.gov.

Authors:  Isaretta L Riley; L Ebony Boulware; Jie-Lena Sun; Karen Chiswell; Loretta G Que; Monica Kraft; Jamie L Todd; Scott M Palmer; Monique L Anderson
Journal:  Clin Trials       Date:  2017-11-10       Impact factor: 2.486

10.  Informed Consent to Study Purpose in Randomized Clinical Trials of Antibiotics, 1991 Through 2011.

Authors:  Peter Doshi; Peter Hur; Mark Jones; Husam Albarmawi; Tom Jefferson; Daniel J Morgan; Patricia A Spears; John H Powers
Journal:  JAMA Intern Med       Date:  2017-10-01       Impact factor: 21.873
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.